Lyllana reviews: is this estradiol patch actually legit?
If your pharmacy handed you Lyllana instead of the patch you expected, it's a real FDA-approved estradiol patch. The real questions are how well it sticks and whether your pharmacy has it in stock.
Medically reviewed by Jill Garnier, MDLyllana is a real, FDA-approved generic estradiol patch — not a compounded product, not an unregulated import, and not a different drug than the brand-name patches it substitutes for. It's manufactured by Amneal Pharmaceuticals under ANDA211396 and shown bioequivalent to Vivelle. The medication itself works the same way any estradiol patch does. The genuine issue is the delivery vehicle: patient reviews are unusually negative specifically about adhesion — the patch lifting, wrinkling, or falling off before its 3-to-4-day wear window is up — and as of September 2026 it's also caught in a nationwide estradiol-patch shortage, so simply finding a box in stock can be the bigger obstacle than the price. If your pharmacy handed you Lyllana as a substitution, the hormone dose you're getting is legitimate; whether the patch itself behaves is the real open question.
On this page
- What you will actually pay
- What is Lyllana, and why did your prescription change to it?
- Is Lyllana FDA-approved, or is it compounded?
- What do Lyllana reviews actually say?
- How much does Lyllana cost, with and without insurance?
- Can't find Lyllana at your pharmacy? The 2026 patch shortage
- Lyllana vs. Alora, Vivelle-Dot, Climara and Minivelle: which estradiol patch is best?
- When should you switch away from Lyllana?
- The bottom line on Lyllana
- Frequently asked questions
What you will actually pay
We may earn a commission if you sign up through a link. It never affects the ranking. How we review
Paying cash with no coupon — use a free discount card instead; retail varies significantly by pharmacy and dosage strength
Get startedUninsured patients, or anyone whose plan doesn't cover Lyllana specifically — CVS and Walmart priced lowest in this research
Get startedInsured patients — generic estradiol patches are usually placed on a low formulary tier, though some plans require a prior trial of a different generic, especially during the current shortage
Get startedNot applicable — no Lyllana-specific manufacturer coupon was found as of Sep 2026; Amneal runs a broader patient assistance program but not a product-specific copay card for this item
Get startedEstimated all-in cost: ~$130–$390/yr with insurance at a typical generic copay tier (about 13 boxes/yr); ~$640–$910/yr cash-pay with a GoodRx or SingleCare coupon; ~$1,820–$2,860/yr at full retail cash price with no discount. In practice, the 2026 nationwide estradiol-patch shortage may make simply finding a box in stock the bigger obstacle than any of these numbers.
- ✓ FDA-approved (ANDA211396) and shown bioequivalent to Vivelle — a real, regulated generic, not a compounded or gray-market product
- ✓ Typically covered at a low generic copay tier ($10–$30/mo) on commercial insurance and Medicare Part D
- ✓ GoodRx and SingleCare coupons bring the cash price down to roughly $49–$70/box, well under most brand-name patches
- ✓ Same hormone (estradiol) and delivery method (twice-weekly transdermal patch) as every other estradiol patch on the market — a pharmacy substitution doesn't change what you're actually taking
- ✓ Five dosage strengths (0.025–0.1 mg/day) allow fine dose titration alongside a prescriber
- ⚑ Adhesion is the single most common and severe patient complaint — reviewers consistently describe the patch lifting at the edges, wrinkling, or detaching well before the intended 3-to-4-day wear window
- ⚑ Caught in a nationwide estradiol-patch shortage through at least late 2026 (per ASHP); CVS, Walgreens, and Optum mail-order have all reported backorders on it
- ⚑ Patient review volume is low and skews heavily negative, which likely overweights people motivated to report a problem — treat the aggregate score as directional, not definitive
- ⚑ No confirmed Lyllana-specific manufacturer copay card, unlike some brand-name patches
- ⚑ Some insurance plans require prior authorization or documentation of a failed trial of a different generic, a requirement that's gotten more common as the shortage has pushed substitution attempts up
What is Lyllana, and why did your prescription change to it?
Lyllana is an FDA-approved estradiol skin patch made by Amneal Pharmaceuticals. You change it twice a week, every 3 to 4 days. Per its FDA label, it treats moderate to severe hot flashes and night sweats from menopause. It also helps prevent bone loss after menopause. It comes in five strengths, from 0.025 to 0.1 mg a day, so your dose can be adjusted in small steps.
Lyllana is the FDA-approved generic of Vivelle. It was approved through the generic pathway, application ANDA211396. Its studies showed it delivers estradiol at the same rate and amount as the brand. If your pharmacy swapped Vivelle-Dot for Lyllana, that's a routine generic swap. It's like getting generic atorvastatin instead of Lipitor, not a downgrade.
Is Lyllana FDA-approved, or is it compounded?
FDA-approved, not compounded. A compounded product is mixed by a pharmacy under looser rules. A generic like Lyllana had to prove it matches an approved brand, and its factory must meet ongoing FDA standards. So Lyllana carries none of the doubts that hang over some compounded hormones.
What do Lyllana reviews actually say?
The complaints are specific. Across patient reviews on Drugs.com, WebMD and review roundups, few women fault the estradiol itself. Those who keep the patch on say it stops hot flashes and night sweats like any estradiol patch. The complaints are about the patch: edges lifting, wrinkling, or falling off before day 3 or 4, sometimes within a day.
Two caveats apply. There are few reviews of Lyllana, and online drug reviews lean toward people with a problem. So read the poor scores as a real signal about sticking, not proof it fails for everyone. If your patch stays on and works, that's not luck. If it doesn't, you're one of many.
How much does Lyllana cost, with and without insurance?
- No coupon, no insurance: about $140 to $220 per box of 8 patches, about four weeks, depending on pharmacy and strength
- With a free coupon: about $50 to $75 a box. SingleCare showed about $60 at CVS and about $73 at Kroger in October 2026.
- Commercial insurance or Medicare Part D: usually your plan's generic-tier copay. Some plans first want prior approval or a trial of another generic.
A box lasts four weeks, so a year takes 13 boxes. With a coupon, that's about $650 to $975 a year. At full cash price with no coupon, it's about $1,820 to $2,860. Pharmacy prices vary that much, so compare a few before you fill.
Can't find Lyllana at your pharmacy? The 2026 patch shortage
If your pharmacy says it's backordered, you're not alone. The American Society of Health-System Pharmacists has listed a shortage of estradiol patches since January 30, 2026. Its last update, on August 12, 2026, named 17 patch packs from five companies. Pharmacies have reported Lyllana, Vivelle-Dot, Climara and Dotti on backorder at times.
Demand drove it. On November 10, 2025, the FDA said it would remove the heart, stroke, breast cancer and dementia lines from the boxed warning on hormone therapy labels. Updated labels began in February 2026, and more women started hormone therapy.
On September 3, 2026, the FDA said estradiol patches remain available, though some brands vary by pharmacy. It said patch supply has nearly doubled over the past year. It is working with all six makers to raise output, but bigger expansions will take time.
If your pharmacy is out, call a few others before you assume the patch is gone. A gel, spray or estradiol pill can bridge the gap if no patch is available nearby.
Lyllana vs. Alora, Vivelle-Dot, Climara and Minivelle: which estradiol patch is best?
- Alora: discontinued. Every strength is listed as discontinued in the US. If you used Alora, a generic estradiol patch is the usual next step.
- Vivelle-Dot: the brand Lyllana copies. You change it twice a week, and it has been caught in the same shortage.
- Climara: you change it once a week instead of twice, which some women find simpler. It's a different patch design.
- Minivelle: twice a week, like Lyllana, in a smaller patch.
No single brand is best. They all deliver estradiol through the skin the same way. The real differences are how often you change them and how well they stick, not how well they work. With so many brands short in 2026, the practical answer is often whichever one your pharmacy has at your dose.
When should you switch away from Lyllana?
First try the standard fixes. Put it on clean, dry, hairless skin. Rotate between the lower belly and buttock. Keep lotion away from the spot, and press the whole edge down firmly. If it still won't last 3 to 4 days, that's a common, fair reason to ask for a change. Another patch brand, a gel, a spray or an estradiol pill are all normal next steps.
The bottom line on Lyllana
Lyllana is a legitimate, FDA-approved estradiol patch, not a compounded or gray-market product. The hormone dose matches the brand it replaces, so a pharmacy swap isn't a downgrade. The caveats are real too. Complaints about sticking are unusually consistent, and the 2026 patch shortage can make finding a box harder than paying for it. For many women it works as intended. If the patch itself is the problem, change the format, not your trust in the medicine.
Frequently asked questions
Is Lyllana the same medication as Vivelle-Dot?+–
Functionally, yes. Lyllana is the FDA-approved generic version of Vivelle — its own pharmacokinetic studies showed it to be bioequivalent, meaning it delivers estradiol into your bloodstream at the same rate and amount. It's manufactured by Amneal Pharmaceuticals under ANDA211396, not by Vivelle-Dot's maker. If your pharmacy switched you from Vivelle-Dot to Lyllana, the hormone dose you're receiving didn't change — only the patch itself, made by a different manufacturer, did.
Is Lyllana compounded, or is it FDA-approved?+–
It's FDA-approved, not compounded. Lyllana went through the FDA's Abbreviated New Drug Application (ANDA) pathway, which requires manufacturers to demonstrate bioequivalence to an already-approved reference drug — in this case, Vivelle. That's a meaningfully different, more regulated process than a compounding pharmacy mixing a custom formulation, and it means Lyllana carries the same FDA oversight, manufacturing standards, and labeling requirements as any other approved generic.
Why is Lyllana so hard to find right now?+–
As of September 2026, Lyllana is part of a broader nationwide shortage of estradiol transdermal patches, tracked by the American Society of Health-System Pharmacists. Two things are driving it: a surge in demand — reportedly around 72% — after the FDA removed the boxed warnings on hormone therapy for cardiovascular disease, breast cancer, and dementia risk in November 2025, and manufacturing capacity that hasn't kept pace. CVS, Walgreens, and Optum mail-order have all reported Lyllana backorders, and competing brands like Vivelle-Dot and Climara are affected too, so switching pharmacies doesn't always solve it. Ask your prescriber about a different delivery format (gel, spray, or oral estradiol) if the patch itself is unavailable everywhere you check.
Does insurance cover Lyllana?+–
Usually, yes — as a generic estradiol patch, it's commonly placed on a low copay tier by commercial insurance and Medicare Part D plans, often in the $10 to $30 range per box. Coverage isn't universal, though: some plans require prior authorization or documentation that you've tried a different generic first, a requirement that's become more common during the current shortage. Check your specific plan's formulary or call member services before assuming a price.
What can I do if my Lyllana patch keeps falling off?+–
This is the most consistent complaint about this specific product, so you're not imagining it. Practical fixes reported by patients and pharmacists include applying to a clean, dry, hairless area (lower abdomen or buttock, not the breast), avoiding lotion or oil near the application site, pressing firmly around the entire edge for 10 seconds after applying, and taping over the edges with medical tape if it still lifts. If it continues to fail despite that, it's a reasonable, common request to ask your prescriber about switching delivery format — a gel, spray, or oral estradiol — or trying a different patch brand if one is in stock.
Is Alora the same as Lyllana? Can I still get Alora?+–
No — Alora is a different, separate estradiol patch brand, and as of 2026 it has been permanently discontinued by AbbVie, across all four of its dosage strengths, with no anticipated return. If you were previously on Alora and searching for it, it isn't coming back; a generic estradiol patch (Lyllana included, when it's in stock) delivers the same hormone and is the standard next step your prescriber will likely suggest.
Which estradiol patch brand is actually best — Lyllana, Vivelle-Dot, Climara, or Minivelle?+–
There's no single winner, because they all deliver the same hormone, estradiol, transdermally — the real differences are application frequency and, right now, which one you can actually find. Climara is applied once weekly instead of twice; Vivelle-Dot and Minivelle are twice-weekly like Lyllana, with Minivelle offered in smaller, more finely dosed increments. Patient adhesion complaints run noticeably higher for Lyllana specifically than for Vivelle-Dot in the reviews surveyed for this page. Given that most of this category is affected by the same 2026 supply shortage, the honest best-brand answer for a lot of women in 2026 is whichever one your pharmacy actually has in stock at your prescribed dose.